Reply: The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities

J Am Coll Cardiol. 2017 Oct 17;70(16):2097-2098. doi: 10.1016/j.jacc.2017.07.795.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cardiac Resynchronization Therapy Devices
  • Cardiac Resynchronization Therapy*
  • Comorbidity
  • Defibrillators, Implantable*